RPRX logo

Royalty Pharma plc (RPRX) Revenue

Annual Revenue:

$2.26B-$90.98M(-3.86%)
December 31, 2024

Summary

  • As of today, RPRX annual revenue is $2.26 billion, with the most recent change of -$90.98 million (-3.86%) on December 31, 2024.
  • During the last 3 years, RPRX annual revenue has fallen by -$25.89 million (-1.13%).
  • RPRX annual revenue is now -3.86% below its all-time high of $2.35 billion, reached on December 31, 2023.

Performance

RPRX Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXincome statement metrics

Quarterly Revenue:

$609.29M+$30.63M(+5.29%)
September 30, 2025

Summary

  • As of today, RPRX quarterly revenue is $609.29 million, with the most recent change of +$30.63 million (+5.29%) on September 30, 2025.
  • Over the past year, RPRX quarterly revenue has increased by +$44.60 million (+7.90%).
  • RPRX quarterly revenue is now -10.92% below its all-time high of $683.97 million, reached on March 31, 2023.

Performance

RPRX Quarterly Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXincome statement metrics

TTM Revenue:

$2.35B+$44.60M(+1.93%)
September 30, 2025

Summary

  • As of today, RPRX TTM revenue is $2.35 billion, with the most recent change of +$44.60 million (+1.93%) on September 30, 2025.
  • Over the past year, RPRX TTM revenue has increased by +$84.27 million (+3.72%).
  • RPRX TTM revenue is now -0.48% below its all-time high of $2.36 billion, reached on June 30, 2023.

Performance

RPRX TTM Revenue Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherRPRXincome statement metrics

RPRX Revenue Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-3.9%+7.9%+3.7%
3Y3 Years-1.1%+6.3%+4.6%
5Y5 Years+24.8%+13.2%+17.1%

RPRX Revenue Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-3.9%+1.2%-10.9%+13.6%-0.5%+5.0%
5Y5-Year-3.9%+24.8%-10.9%+13.7%-0.5%+17.1%
All-TimeAll-Time-3.9%+41.7%-10.9%+40.1%-0.5%+440.4%

RPRX Revenue History

DateAnnualQuarterlyTTM
Sep 2025
-
$609.29M(+5.3%)
$2.35B(+1.9%)
Jun 2025
-
$578.66M(+1.8%)
$2.31B(+1.8%)
Mar 2025
-
$568.25M(-4.3%)
$2.26B(+0.0%)
Dec 2024
$2.26B(-3.9%)
$594.00M(+5.2%)
$2.26B(-0.1%)
Sep 2024
-
$564.69M(+5.1%)
$2.27B(+1.3%)
Jun 2024
-
$537.27M(-5.4%)
$2.24B(-0.0%)
Mar 2024
-
$567.98M(-4.7%)
$2.24B(-4.9%)
Dec 2023
$2.35B(+5.2%)
$596.00M(+11.1%)
$2.35B(+1.3%)
Sep 2023
-
$536.31M(-0.4%)
$2.32B(-1.6%)
Jun 2023
-
$538.20M(-21.3%)
$2.36B(+0.1%)
Mar 2023
-
$683.97M(+20.8%)
$2.36B(+5.4%)
Dec 2022
$2.24B(-2.3%)
$566.00M(-1.3%)
$2.24B(-0.4%)
Sep 2022
-
$573.46M(+7.0%)
$2.25B(-0.5%)
Jun 2022
-
$535.96M(-4.6%)
$2.26B(-0.8%)
Mar 2022
-
$562.05M(-2.4%)
$2.28B(-0.5%)
DateAnnualQuarterlyTTM
Dec 2021
$2.29B(+7.9%)
$576.00M(-1.7%)
$2.29B(+0.2%)
Sep 2021
-
$585.77M(+5.6%)
$2.29B(+2.1%)
Jun 2021
-
$554.96M(-3.2%)
$2.24B(+2.0%)
Mar 2021
-
$573.03M(+0.2%)
$2.19B(+3.4%)
Dec 2020
$2.12B(+17.0%)
$572.00M(+6.2%)
$2.12B(+5.7%)
Sep 2020
-
$538.40M(+5.4%)
$2.01B(+3.8%)
Jun 2020
-
$510.93M(+2.0%)
$1.93B(+2.8%)
Mar 2020
-
$500.88M(+9.5%)
$1.88B(+3.6%)
Dec 2019
$1.81B(+1.1%)
$457.49M(-1.5%)
$1.81B(+33.7%)
Sep 2019
-
$464.28M(+1.5%)
$1.36B(+52.0%)
Jun 2019
-
$457.61M(+5.2%)
$892.49M(+105.2%)
Mar 2019
-
$434.88M
$434.88M
Dec 2018
$1.79B(+12.3%)
-
-
Dec 2017
$1.60B(-14.9%)
-
-
Dec 2016
$1.88B(+13.6%)
-
-
Dec 2015
$1.65B
-
-

FAQ

  • What is Royalty Pharma plc annual revenue?
  • What is the all-time high annual revenue for Royalty Pharma plc?
  • What is Royalty Pharma plc annual revenue year-on-year change?
  • What is Royalty Pharma plc quarterly revenue?
  • What is the all-time high quarterly revenue for Royalty Pharma plc?
  • What is Royalty Pharma plc quarterly revenue year-on-year change?
  • What is Royalty Pharma plc TTM revenue?
  • What is the all-time high TTM revenue for Royalty Pharma plc?
  • What is Royalty Pharma plc TTM revenue year-on-year change?

What is Royalty Pharma plc annual revenue?

The current annual revenue of RPRX is $2.26B

What is the all-time high annual revenue for Royalty Pharma plc?

Royalty Pharma plc all-time high annual revenue is $2.35B

What is Royalty Pharma plc annual revenue year-on-year change?

Over the past year, RPRX annual revenue has changed by -$90.98M (-3.86%)

What is Royalty Pharma plc quarterly revenue?

The current quarterly revenue of RPRX is $609.29M

What is the all-time high quarterly revenue for Royalty Pharma plc?

Royalty Pharma plc all-time high quarterly revenue is $683.97M

What is Royalty Pharma plc quarterly revenue year-on-year change?

Over the past year, RPRX quarterly revenue has changed by +$44.60M (+7.90%)

What is Royalty Pharma plc TTM revenue?

The current TTM revenue of RPRX is $2.35B

What is the all-time high TTM revenue for Royalty Pharma plc?

Royalty Pharma plc all-time high TTM revenue is $2.36B

What is Royalty Pharma plc TTM revenue year-on-year change?

Over the past year, RPRX TTM revenue has changed by +$84.27M (+3.72%)
On this page